Continuous Antibiotic Prophylaxis in Pediatric Urology

Area of Science:

• Pediatric Nephrology
• Infectious Diseases
• Pharmacology

Background:

• Urinary tract infections (UTIs) are common in children with vesicoureteral reflux, hydronephrosis, and hydroureteronephrosis.
• Continuous antibiotic prophylaxis (CAP) is a common strategy for UTI prevention in these pediatric patients.
• Concerns exist regarding the long-term effects of CAP, including antibiotic resistance and microbiome disruption.

Purpose of the Study:

• To review the current evidence for continuous antibiotic prophylaxis (CAP) in children with specific urinary tract abnormalities.
• To advocate for a more selective approach to CAP based on individual risk factors.
• To explore potential side effects and alternatives to CAP.

Main Methods:

• Systematic review of existing literature on CAP for pediatric UTIs.
• Analysis of individual risk factors associated with vesicoureteral reflux, hydronephrosis, and hydroureteronephrosis.
• Evaluation of short-term and long-term side effects of CAP, including impact on bacterial resistance and the microbiome.
• Review of alternative prophylactic strategies.

Main Results:

• A selective use of CAP is recommended, targeting children with identifiable risk factors for UTI.
• Potential adverse effects of CAP include increased bacterial resistance and negative impacts on the gut microbiome.
• Alternative strategies such as Vaccinium macrocarpon, probiotics, and vaccines show promise.

Conclusions:

• Selective use of CAP can optimize treatment benefits while minimizing risks in children with urinary tract conditions.
• Further research is needed to validate alternative prophylactic measures and understand long-term outcomes.
• Personalized risk assessment is crucial for guiding CAP decisions in pediatric urology.